secondary myelodysplastic syndromes

Known as: Secondary MDS, Secondary Myelodysplastic Syndrome, myelodysplastic syndromes, secondary 
A myelodysplastic syndrome resulting from chemotherapy or radiation therapy treatment for other malignant disorders.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Germline GATA2 mutations cause cellular deficiencies with high propensity for myeloid disease. We investigated 426 children and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Recent studies have highlighted issues with the International Prognostic Scoring System (IPSS) model in relation to… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
We analyzed outcomes after hematopoietic cell transplantation (HCT) in 257 patients, 3 to 72.7 years old (median, 43 y), with… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Review
2006
Review
2006
During therapy with imatinib, some patients with chronic myeloid leukemia (CML) develop chromosomal abnormalities in Philadelphia… (More)
  • table 1
Is this relevant?
2005
2005
We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant… (More)
Is this relevant?
Review
2003
Review
2003
Myelodysplastic and myeloproliferative disorders are rare in childhood and there is no widely accepted system for their diagnosis… (More)
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2000
2000
BACKGROUND AND OBJECTIVE Secondary myelodysplastic syndromes (sMDS) and secondary acute myeloid leukemias (sAML) have been… (More)
Is this relevant?
1995
1995
Cytogenetic analyses were performed on 266 bone marrow and peripheral blood samples from 179 patients with myelodysplastic… (More)
  • table I
  • table 2
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE To analyze the risk of developing myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) following autologous… (More)
Is this relevant?
1989
1989
Therapeutic options for children with de novo or secondary myelodysplastic syndromes (MDSs) are limited. We report the outcome of… (More)
  • table 1
  • table 2
Is this relevant?